| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antithrombotic Agents in Coronary Artery Disease
|
Cairns, John A.
|
|
1992
|
102 |
4S |
p. 456S-481S
nvt p.
|
artikel
|
| 2 |
Antithrombotic Therapy for Cerebrovascular Disorders
|
Sherman, David G.
|
|
1992
|
102 |
4S |
p. 529S-537S
nvt p.
|
artikel
|
| 3 |
Antithrombotic Therapy for Venous Thromboembolic Disease
|
Hyers, Thomas M.
|
|
1992
|
102 |
4S |
p. 408S-425S
nvt p.
|
artikel
|
| 4 |
Antithrombotic Therapy in Atrial Fibrillation
|
Laupacis, Andreas
|
|
1992
|
102 |
4S |
p. 426S-433S
nvt p.
|
artikel
|
| 5 |
Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves
|
Stein, Paul D.
|
|
1992
|
102 |
4S |
p. 445S-455S
nvt p.
|
artikel
|
| 6 |
Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts Following Percutaneous Transluminal Coronary Angioplasty
|
Stein, Paul D.
|
|
1992
|
102 |
4S |
p. 508S-515S
nvt p.
|
artikel
|
| 7 |
Antithrombotic Therapy in Peripheral Arterial Occlusive Disease
|
Clagett, G. Patrick
|
|
1992
|
102 |
4S |
p. 516S-528S
nvt p.
|
artikel
|
| 8 |
Antithrombotic Therapy in Valvular Heart Disease
|
Levine, Herbert J.
|
|
1992
|
102 |
4S |
p. 434S-444S
nvt p.
|
artikel
|
| 9 |
Aspirin and Other Platelet-Active Drugs
|
Hirsh, Jack
|
|
1992
|
102 |
4S |
p. 327S-336S
nvt p.
|
artikel
|
| 10 |
Assessment of the Therapeutic Use of n-3 Fatty Acids in Vascular Disease and Thrombosis
|
Goodnight, Scott H.
|
|
1992
|
102 |
4S |
p. 374S-384S
nvt p.
|
artikel
|
| 11 |
Coronary Thrombolysis
|
Cairns, John A.
|
|
1992
|
102 |
4S |
p. 482S-507S
nvt p.
|
artikel
|
| 12 |
Decision Analytic and Cost-Effectiveness Issues Concerning Anticoagulant Prophylaxis in Heart Disease
|
Eckman, Mark H.
|
|
1992
|
102 |
4S |
p. 538S-549S
nvt p.
|
artikel
|
| 13 |
Hemorrhagic Complications of Anticoagulant Treatment
|
Levine, Mark N.
|
|
1992
|
102 |
4S |
p. 352S-363S
nvt p.
|
artikel
|
| 14 |
Hemorrhagic Complications of Thrombolytic Therapy in the Treatment of Myocardial Infarction and Venous Thromboembolism
|
Levine, Mark N.
|
|
1992
|
102 |
4S |
p. 364S-373S
nvt p.
|
artikel
|
| 15 |
Heparin: Mechanism of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and Safety
|
Hirsh, Jack
|
|
1992
|
102 |
4S |
p. 337S-351S
nvt p.
|
artikel
|
| 16 |
Oral Anticoagulants
|
Hirsh, Jack
|
|
1992
|
102 |
4S |
p. 312S-326S
nvt p.
|
artikel
|
| 17 |
Prevention of Venous Thromboembolism
|
Clagett, G. Patrick
|
|
1992
|
102 |
4S |
p. 391S-407S
nvt p.
|
artikel
|
| 18 |
Rules of Evidence and Clinical Recommendations on the Use of Antithrombotic Agents
|
Cook, Deborah J.
|
|
1992
|
102 |
4S |
p. 305S-311S
nvt p.
|
artikel
|
| 19 |
Use of Antithrombotic Agents During Pregnancy
|
Ginsberg, Jeffrey S.
|
|
1992
|
102 |
4S |
p. 385S-390S
nvt p.
|
artikel
|
Tijdschrift beschrijving